Arjan J. Verschoor
Delft, ZH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Survival of patients with colorectal or pancreatic cancer who received UGT1A1 genotype-guided dosing of irinotecan in the Netherlands (2017-2024): a retrospective, multicentre cohort study.
Journal: The Lancet regional health. Europe
Published: November 14, 2025
Real-World Impact of UGT1A1 Genotype-Guided Irinotecan Dosing on Severe Toxicity and Hospitalization: A Multicenter Study.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: November 05, 2025
Effects of exercise and diet in patients with incurable gastroesophageal cancer: the RADICES study.
Journal: JNCI cancer spectrum
Published: August 29, 2025
Health-Related Quality of Life in Adolescents and Young Adults With an Uncertain or Poor Cancer Prognosis: Quantitative Baseline Results of the CORD-AYA Study.
Journal: Psycho-oncology
Published: July 31, 2025
DOSAGE study: protocol for a phase III non-inferiority randomised trial investigating dose-reduced chemotherapy for advanced colorectal cancer in older patients.
Journal: BMJ open
Published: August 14, 2024
Time trends in treatment patterns and survival of older patients with synchronous metastatic colorectal cancer in the Netherlands: A population-based study.
Journal: International journal of cancer
Published: October 20, 2022
Risk of venous thromboembolism and major bleeding in the clinical course of osteosarcoma and Ewing sarcoma.
Journal: Thrombosis research
Published: September 20, 2022
Higher incidence rates than previously known in tenosynovial giant cell tumors.
Journal: Acta orthopaedica
Published: August 09, 2017
Imatinib-induced agranulocytosis in patients with gastrointestinal stromal tumors.
Journal: Journal of clinical pharmacology
Published: March 27, 2015
Showing 1-9 of 9
Last Updated: 09/26/2026